OLGC to begin Phase III fracture trial

OrthoLogic (OLGC) will begin this fall a U.S. Phase III trial of Chrysalin to accelerate fracture repair in 500 patients. OLGC expects enrollment to last 24 months with a six-month follow-up period. T...